Prana Biotechnology Limited (ASX:PBT) Share Price, News, Chart & Financials

Prana Biotechnology Limited

Sector: Healthcare

Description

Prana Biotechnology Limited (ASX: PBT) for a part of health care industry which is into the business of developing first-in-class therapies for neurodegenerative diseases to treat orphans. The company’s board of directors holds a vast research, pharmaceutical and financial industries experience along with strong research and development advisory board which consist of scientists and professional research experts. The company was founded in year 1997 and its headquarters is in Australia.

Peers

NVAX

Novavax Inc

ANP

Antisense Therapeutics Ltd.

PTX

Prescient Therapeutics Limited

MRNA

Moderna Inc

NOX

Noxopharm Limited

IMU

Imugene Limited

SKN

Skin Elements Ltd

PFE

Pfizer Inc

CHM

Chimeric Therapeutics Limited

RAD

Radiopharm Theranostics Limited

BPH

BPH Energy Limited

CYP

Cynata Therapeutics Limited

Close

Companies View All

Articles View All

Definitions View All

Live News View All

Prana Biotechnology Limited

Prana Biotechnology Limited

Description

Peers

NVAX

ANP

PTX

MRNA

NOX

IMU

SKN

PFE

CHM

RAD

BPH

CYP

Sponsored Articles

Related Articles